Free Trial
NASDAQ:HYPR

Hyperfine (HYPR) Stock Price, News & Analysis

Hyperfine logo
$0.99 +0.00 (+0.15%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Hyperfine Stock (NASDAQ:HYPR)

Key Stats

Today's Range
$0.95
$0.99
50-Day Range
$0.85
$1.06
52-Week Range
$0.76
$1.39
Volume
51,301 shs
Average Volume
122,650 shs
Market Capitalization
$72.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.60
Consensus Rating
Hold

Company Overview

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Hyperfine Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
39th Percentile Overall Score

HYPR MarketRank™: 

Hyperfine scored higher than 39% of companies evaluated by MarketBeat, and ranked 707th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Hyperfine has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Hyperfine has received no research coverage in the past 90 days.

  • Read more about Hyperfine's stock forecast and price target.
  • Earnings Growth

    Earnings for Hyperfine are expected to grow in the coming year, from ($0.57) to ($0.53) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Hyperfine is -1.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Hyperfine is -1.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Hyperfine has a P/B Ratio of 0.84. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.77% of the float of Hyperfine has been sold short.
  • Short Interest Ratio / Days to Cover

    Hyperfine has a short interest ratio ("days to cover") of 12.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Hyperfine has recently increased by 0.68%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Hyperfine does not currently pay a dividend.

  • Dividend Growth

    Hyperfine does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.77% of the float of Hyperfine has been sold short.
  • Short Interest Ratio / Days to Cover

    Hyperfine has a short interest ratio ("days to cover") of 12.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Hyperfine has recently increased by 0.68%, indicating that investor sentiment is decreasing.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Hyperfine this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for HYPR on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Hyperfine to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Hyperfine insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,380.00 in company stock.

  • Percentage Held by Insiders

    29.42% of the stock of Hyperfine is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 15.03% of the stock of Hyperfine is held by institutions.

  • Read more about Hyperfine's insider trading history.
Receive HYPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter.

HYPR Stock News Headlines

NeuroPace appoints Scott Huennekens to board
Hyperfine announces new distribution partnerships in EMEA
Please take this warning seriously...
I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader in the country – in the next 30 days. In fact, I believe it could begin as soon as January 29th… Meaning you don’t have much time to prepare.
Hyperfine, Inc. Reports Record Revenue Growth in Q3 2024
See More Headlines

HYPR Stock Analysis - Frequently Asked Questions

Hyperfine's stock was trading at $0.88 at the beginning of 2025. Since then, HYPR shares have increased by 12.3% and is now trading at $0.9881.
View the best growth stocks for 2025 here
.

Hyperfine, Inc. (NASDAQ:HYPR) released its earnings results on Tuesday, November, 12th. The company reported ($0.14) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.14). The business had revenue of $3.64 million for the quarter, compared to the consensus estimate of $3.40 million. Hyperfine had a negative net margin of 309.42% and a negative trailing twelve-month return on equity of 57.54%.

Top institutional shareholders of Hyperfine include Graypoint LLC (0.07%). Insiders that own company stock include Hc Sponsor Llc, Jonathan M Rothberg, Alok Gupta, Neela Paykel, Thomas Teisseyre and Khan Siddiqui.
View institutional ownership trends
.

Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hyperfine investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), Paycom Software (PAYC), Adobe (ADBE) and Jabil (JBL).

Company Calendar

Last Earnings
11/12/2024
Today
1/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:HYPR
Fax
N/A
Employees
190
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.60
High Stock Price Target
$1.60
Low Stock Price Target
$1.60
Potential Upside/Downside
+61.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-44,240,000.00
Net Margins
-309.42%
Pretax Margin
-309.42%

Debt

Sales & Book Value

Annual Sales
$13.26 million
Book Value
$1.17 per share

Miscellaneous

Free Float
51,487,000
Market Cap
$72.08 million
Optionable
Optionable
Beta
0.88
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (NASDAQ:HYPR) was last updated on 1/27/2025 by MarketBeat.com Staff
From Our Partners